Bayer/Syngenta agree settlement on three GMO patents
Bayer CropScience has settled out of court in the US with Syngenta over patent rights for three unnamed genetically modified seed traits. Syngenta had challenged the validity of Bayer’s US patents on the insect-resistance traits, Bayer confirmed to Agrow. The companies agreed to provide no further information. The case was closed at the US District Court for the District of Columbia. The traits are part of licensing negotiations between the companies, US business law newswire Law 360 reports.